Herpesvirus Infection in Development of Hemorrhagic Vasculitis in Children (Literature Review)

  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract

    The authors conducted a systematic review of the literature published in the last fifteen years. The results of the literature review showed that the role of herpesvirus infection in the occurrence of primary vasculitis is not excluded. In the works of Kazakhstan and foreign researchers who consider that ability of viruses to cytopathic effect is important for herpesvirus infection, herpes simplex infection is not excluded as a leading factor in the development of HV. In this regard, the study of the etiology of HV will help to reach a new therapeutic level of the disease. Consequently, the problem of HV is of scientific interest and practical importance.




  • Keywords

    hemorrhagic vasculitis, children, herpes simplex virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus.

  • References

      [1] Dolezalova P, Cummings C, Southwood TR (2002), Morbidity of Henoch-Shonlein purpura, Kawasaki disease and rare vasculitis in children of different ethnic origin. Lancet, 360, pp: 1197-1202.

      [2] Hung SP, Yang YH, Lin YT et al (2009), Clinical manifestations and results of Henoch-Shonlein purpura: comparison between adults and children. Pediatrician Neonatol, 50 (4), pp: 162-168.

      [3] Jauhola O, Ronkainen J, Koskimies O (2010), Renal manifestations of Henoch-Shonlein purpura in 6-month prospective study of 223 children. Archives of Disease in Childhood, 95 (11), pp: 877-882.

      [4] Magichnost S, Balma-Mena A, Pope E, Weinstein M (2010), Bullous Henoch-Schönlein purpura in children: report on 6 cases and review of the literature. Clinical Pediatrics (Philadelphia), 49(11), pp: 1033-1037.

      [5] Hospach T, Klaus G, Holl-Ulrich K et al (2008), Schoenlein-Enoch Purpura. Clinical Pediatrics, 220 (1), pp: 47-52.

      [6] Saulsbury FT (2010), Purpura Henoch-Schönlein. Current Opinion in Rheumatology, 22 (5), pp: 598-602.

      [7] Weller F, Hospach T, Dannecker G, Huppertz HI (2007), Schoenlein-Enoch Purpura. Pediatric practice, 70, pp: 77-92.

      [8] Zhao L, Li Y (2017), Retrospective analysis on 337 cases of sep Henoch-Schonlein purpura. Zhonq Nan Da XueXueBao Yi Xue Ban, 42 (1), pp: 72-77, https://doi.org/10.11817/j.issn.1672-7347.2017.

      [9] Kummerle-Deschner JB, Thomas J, Benseler SM (2015), Childhood vasculitis. Zeitschrift fur rheumatologie, 10(74), pp: 863.

      [10] Murakami X, Takahashi S, Kawakubo Y, Kinukawa N, Funaki S, Harada K (2008), Teenager with glomerulonephritis purpura Henoch-Shonline and intracranial hemorrhage, possibly secondary to reactivation of latent CMV. Pediatrics International, 50(1),
      pp: 112-115.

      [11] Croche Santander B, Campos E, Sanchez A, Marcos L, Diaz I, Toro C (2017), Purpura de Schönlein - Henoch con afectacion peniana. Caso clinico. Archivos argentinos de pediatria, 4(115), pp: 249-251.

      [12] Kharlamova FS, Egorova NYu, Shamsheva OV, Walts NL, Denisova AV (2016), HV on the background of actively persisting herpesvirus infections. Attending physician, 9, pp: 74-77.

      [13] Okhotnikova EN, Gladush YuI, Ivanova TP (2010), Systemic vasculitis in the practice of pediatric allergist. Clinical immunology, allergology, infectology, 4, pp: 6-21.

      [14] Kharlamova FS, Uchaikin VF, Legkova TP, Feldfiks LI (2012), Combination therapy with persistent herpesvirus infection in frequently ill children. Children's infections, 4, pp: 31-36.

      [15] Bokova AG (2010), Herpesvirus infections in children – urgent problem of modern clinical practice. Infant Infections, 2, pp: 54-59.

      [16] Sonina OI, Kikinskaya EG, Lyskina GA, Zinovieva GA (2008), The role of infection in the development and course of Shenlaine-Henoch disease in children. Pediatrics, 87(2), pp: 35-39.

      [17] Karetnikova VM, Petrunko IL (2017), Clinico-expert case of eosinophilic granulomatous vasculitis. Asta biomedical scientifica, 3(2), pp: 106-109.

      [18] Kazmirchuk VV, Maltsev DV (2010), Retrospective analysis of use of Geprimun-6 in patients with infection caused by HSV of type 6. Clinical immunology, allergology, infectiology, 6(34), pp: 64-70.

      [19] Bao L, Cowan MJ, Dunham K et al (2012), Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections. Journal of Immunotherapy, 35(3), pp: 293-298.

      [20] Doubrovina E, Oflaz-Sozmen B, Prockop SE et al (2012), Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood, 119(11), pp: 2644–2656.

      [21] Kudashov NI, Sukhikh GT, Orlovskaya IV, Ozerova OE, Faizullin LZ (2011), Herpes-viral infection in newborns. Zemsky doctor, 5(9), pp: 9-12.

      [22] Lalezary M, Recchia FM, Kim SJ (2012), Treatment of congenital CMV retinitis with intravitreous ganciclovir. Archives of ophthalmology, 130(4), pp: 525–527.

      [23] Nigro G, Adler SP, Parruti G et al (2012), Immunoglobulin therapy of fetal CMV infection occurring in the first half of pregnancy –
      a case-control study of the outcome in children. The Journal of Infectious Diseases, 205(2), pp: 215–227.

      [24] Duse M, Iacobini M, Leonardi L et al (2010), Transient hypogammaglobulinemia of infancy: intravenous immunoglobulin as first line therapy. International Journal of Immunopathology and Pharmacology, 23(1), pp: 349–353.

      [25] Garty BZ, Pollak U, Scheuerman O, Marcus N, Hoffer V (2006), Acute hemorrhagic edema of infancy associated with herpes simplex type 1 stonatitis. Pediatric Dermatology, 23(4), pp: 361-364.

      [26] Snider SB, Jacobs CS, Scripko PS, Klein JP, Lyons JL (2014), Hemorrhagic and ischemic stroke secondary to HSV type 2 meningitis and vasculopathy. The Journal of NeuroVirology, 20(4),
      pp: 419-22, doi:10.1007/s13365-014-0253-7.Epub 2014 May 8.

      [27] Eqorova ON, Balabanova RM, Chuvirov GN (2003), Significance of antibodies to herpesviridae viruses detectable in rheumatic diseases. Terapevticheskii arkhiv, 70(5), pp: 41-45.

      [28] Moraru M, Carbone J, Alecsandru D (2012), Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. American Journal of Reproductive Immunology, 68(1),
      pp: 75-84.

      [29] Chan H, Tang YL, Lv XN, Zhang GF, Wang M, Yang HP, Li Q (2016), Risk Factors Assjciated with Renal Involvement in Childhood Henoch – chonlein Purpura: A Meta-Analysis. PLoS One, 11(11), doi: 10.1371/journal pone.0167346.

      [30] Dylewska M, Wieliczko M (2016), IgA vasculitis (Henoch-Schonlein Purpura). Wiadomości Lekarskie, 69(5), pp: 711-713.

      [31] Ramelli V, Lava SA, Simonetti GD, Bianchetti MG, Ramellli GP, Milani GP (2017), Blistering eruptions in childhood Henoch-Schonlein syndrome:systematic review of the literature. European Journal of Pediatrics, 176(4), pp: 487-492.

      [32] Chelpan LL (2011), Features of therapy for HV associated with streptococcal infection. Bukovins'kiy medichniy visnik, 1(15),
      pp: 107-109.

      [33] Egorova NYu, Guseva LN, Guseva NA, Novosad EV, Rakhalina AA, Rogova LA, Uchaikin VF (2008), Significance of markers of herpes viruses for state evaluation of children's health. Children's infections, 6, pp: 62-69.

      [34] Podchernyaeva NS, Kudryashova MA, Frolkova EV, Korotkova EA, Dashkova NG (2016), Clinical significance of hemostatic disorders in iga-vasculitis (henoch-schonlein) in children. New Armenian Medical Journal, 3(10), pp: 43-51.




Article ID: 24494
DOI: 10.14419/ijet.v7i4.38.24494

Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.